International Patent: CROSS-CELL-GROUP INDICATION FOR SECONDARY CELL ACTIVATION

GENEVA, Oct. 15 -- QUALCOMM INCORPORATED filed a patent application (CN2025/087422) for “CROSS-CELL-GROUP INDICATION FOR SECONDARY CELL ACTIVATION”. With publication no. WO/2026/213714, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: H04W 72/21

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....